Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic ColitisStephan Miehlke, Wolfgang Kruis, Michael Bläker et al.|Gastroenterology|2018Cited by 70
Distribution of histopathological features along the colon in microscopic colitisAnne‐Marie Kanstrup Fiehn, Andreas Münch, Stephan Miehlke et al.|International Journal of Colorectal Disease|2020Cited by 28
Efficacy and safety of prolonged release budesonide granules in mesalazine‐refractory ulcerative colitis: A multi‐centre Phase IIa study (TOPICAL‐1)Klaus Fellermann, Roland Greinwald, I Rácz et al.|United European Gastroenterology Journal|2020Cited by 5
Budesonide is superior to mesalazine and placebo for induction of remission in lymphocytic colitisStephan Miehlke, Andreas Münch, Daniela E. Aust et al.|Lithuanian University of Health Sciences|2017Cited by 1
Tu1741 – A Novel Oral Formulation of Budesonide is Effective for Induction of Remission in Mesalamine Refractory Ulcerative Colitis (TOPICAL-1)Klaus Fellermann, Roland Greinwald, Ingolf Schiefke et al.|Gastroenterology|2019Cited by 0